Fresenius Medical Care will purchase a 19% stake in Humacyte, which closed a $75m series C round in March 2018.

Exor Seeds will invest in technology startups, with PartnerRe and Exor each providing half the capital for the fund.

Fresenius Medical Care will purchase a 19% stake in Humacyte, which closed a $75m series C round in March 2018.

Sensome develops micro-sensor systems for medical devices which exploit impedance together with machine learning algorithms to reliably identify biological tissues.

The UCL spinout has set the pricing range at $15 to $17 and stands to raise nearly $144m in proceeds if underwriters take up their 30-day option.

Pivotal BioVenture Partners China and Nan Fung Life Sciences itself have taken part in a $16.5m seed round in Oncologie as the startup launched operations in Shanghai and Boston.

Duke spinout Precision BioSciences, whose investors include Amgen and Baxter, has raised an initial $88m in series B funding out of a $110m target.

Duke spinout Precision BioSciences, whose investors include Amgen and Baxter, has raised an initial $88m in series B funding out of a $110m target.

Kadmon-backed gene therapy developer MeiraGTx has gone public on Nasdaq after raising $75m in proceeds in its initial public offering.